Ampisid (Powder) Instructions for Use
Marketing Authorization Holder
Mustafa Nevzat Pharmaceutical Industry, A.S. (Turkey)
ATC Code
J01CR04 (Sultamicillin)
Active Substance
Sultamicillin (Rec.INN registered by WHO)
Dosage Form
| Ampisid | Powder for preparation of oral suspension 250 mg/5 ml: bottle 70 ml 1 pc. |
Dosage Form, Packaging, and Composition
| Powder for preparation of oral suspension | 5 ml of prepared susp. |
| Sultamicillin | 250 mg |
Dark glass bottles with a volume of 70 ml (1) complete with a dosing spoon – cardboard packs.
Clinical-Pharmacological Group
Broad-spectrum penicillin antibiotic with a beta-lactamase inhibitor
Pharmacotherapeutic Group
Antibiotic, semi-synthetic penicillin + beta-lactamase inhibitor
Pharmacological Action
Broad-spectrum antibacterial agent. It is a double ester of ampicillin (a semi-synthetic penicillin) and sulbactam (a beta-lactamase inhibitor). It acts bactericidally.
Sultamicillin is active against gram-positive and gram-negative bacteria, including those producing β-lactamases.
Indications
Infectious and inflammatory diseases caused by microorganisms sensitive to sultamicillin (including gonococci).
Continuation of therapy after a course of treatment with a combination of ampicillin and sulbactam administered parenterally.
ICD codes
| ICD-10 code | Indication |
| A54 | Gonococcal infection |
| H66 | Suppurative and unspecified otitis media |
| J01 | Acute sinusitis |
| J02 | Acute pharyngitis |
| J03 | Acute tonsillitis |
| J04 | Acute laryngitis and tracheitis |
| J15 | Bacterial pneumonia, not elsewhere classified |
| J20 | Acute bronchitis |
| J31.2 | Chronic pharyngitis |
| J32 | Chronic sinusitis |
| J35.0 | Chronic tonsillitis |
| J37 | Chronic laryngitis and laryngotracheitis |
| J42 | Unspecified chronic bronchitis |
| K81.0 | Acute cholecystitis |
| K81.1 | Chronic cholecystitis |
| K83.0 | Cholangitis |
| L01 | Impetigo |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| L03 | Cellulitis |
| L08.0 | Pyoderma |
| L08.8 | Other specified local infections of skin and subcutaneous tissue |
| M00 | Pyogenic arthritis |
| M86 | Osteomyelitis |
| N10 | Acute tubulointerstitial nephritis (acute pyelonephritis) |
| N11 | Chronic tubulointerstitial nephritis (chronic pyelonephritis) |
| N30 | Cystitis |
| N34 | Urethritis and urethral syndrome |
| N37.0 | Urethritis in diseases classified elsewhere |
| N41 | Inflammatory diseases of prostate |
| N70 | Salpingitis and oophoritis |
| N71 | Inflammatory disease of uterus, excluding cervix (including endometritis, myometritis, metritis, pyometra, uterine abscess) |
| N72 | Inflammatory disease of cervix uteri (including cervicitis, endocervicitis, exocervicitis) |
| N74.3 | Gonococcal inflammatory diseases of female pelvic organs |
| T79.3 | Posttraumatic wound infection, not elsewhere classified |
| ICD-11 code | Indication |
| 1A7Z | Gonococcal infection, unspecified |
| 1B70.1 | Streptococcal cellulitis of the skin |
| 1B70.2 | Staphylococcal cellulitis of the skin |
| 1B70.Z | Bacterial cellulitis or lymphangitis caused by unspecified bacterium |
| 1B72.0 | Bullous impetigo |
| 1B72.1 | Nonbullous impetigo |
| 1B72.Z | Impetigo, unspecified |
| 1B75.0 | Furuncle |
| 1B75.1 | Carbuncle |
| 1B75.2 | Furunculosis |
| 1B75.3 | Pyogenic skin abscess |
| 1B7Y | Other specified pyogenic bacterial infections of skin or subcutaneous tissue |
| 1C44 | Non-pyogenic bacterial infections of skin |
| AA9Z | Unspecified suppurative otitis media |
| CA01 | Acute rhinosinusitis |
| CA02.Z | Acute pharyngitis, unspecified |
| CA03.Z | Acute tonsillitis, unspecified |
| CA05 | Acute laryngitis or tracheitis |
| CA09.2 | Chronic pharyngitis |
| CA0A.Z | Chronic rhinosinusitis, unspecified |
| CA0F.Y | Other specified chronic diseases of the palatine tonsils and adenoids |
| CA0G | Chronic laryngitis or laryngotracheitis |
| CA20.1Z | Chronic bronchitis, unspecified |
| CA40.0Z | Bacterial pneumonia, unspecified |
| CA42.Z | Acute bronchitis, unspecified |
| DC12.0Z | Acute cholecystitis, unspecified |
| DC12.1 | Chronic cholecystitis |
| DC13 | Cholangitis |
| EA50.3 | Staphylococcal scarlet fever |
| EB21 | Pyoderma gangrenosum |
| FA1Z | Infectious arthropathies, unspecified |
| FB84.Z | Osteomyelitis or osteitis, unspecified |
| GA01.Z | Inflammatory diseases of uterus, except cervix, unspecified |
| GA07.Z | Salpingitis and oophoritis, unspecified |
| GA91.Z | Inflammatory and other diseases of prostate, unspecified |
| GB50 | Acute tubulo-interstitial nephritis |
| GB51 | Acute pyelonephritis |
| GB55.Z | Chronic tubulo-interstitial nephritis, unspecified |
| GB5Z | Renal tubulo-interstitial diseases, unspecified |
| GC00.Z | Cystitis, unspecified |
| GC02.1 | Nonspecific urethritis |
| GC02.Z | Urethritis and urethral syndrome, unspecified |
| NF0A.3 | Posttraumatic wound infection, not elsewhere classified |
| 1A71 | Gonococcal pelviperitonitis |
| GA05.Z | Inflammatory diseases of female pelvic organs, unspecified |
| GA0Z | Inflammatory diseases of female genital tract, unspecified |
| XA5WW1 | Cervix uteri |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
For adults and children weighing more than 30 kg, the daily dose is 375-750 mg/day, for children weighing less than 30 kg – 25-50 mg/kg (depending on the severity of the infection).
The frequency of administration is 2 times/day. The course of treatment is 5-14 days.
When treating uncomplicated gonorrhea, Sultamicillin may be prescribed as a single dose of 2.25 g (in combination with probenecid).
Adverse Reactions
From the digestive system: diarrhea; rarely – nausea, vomiting, epigastric pain, colic, enterocolitis and pseudomembranous colitis.
From the CNS: rarely – drowsiness, malaise, headache.
Allergic reactions: itching, rash, skin reactions; in some cases – severe anaphylactic reactions.
Other: development of superinfection (including fungal).
Contraindications
Hypersensitivity to penicillins.
Use in Pregnancy and Lactation
The safety of using sultamicillin during pregnancy and lactation has not been established.
Use in Renal Impairment
In severe renal impairment, the intervals between doses should be increased.
Pediatric Use
Use is possible according to the dosing regimen.
Special Precautions
Sultamicillin should not be used in patients with infectious mononucleosis.
If there is a history of allergic reactions to cephalosporins, the possibility of cross-allergy should be considered.
In severe renal impairment, the intervals between doses should be increased.
During long-term treatment with sultamicillin, peripheral blood counts, liver and kidney function should be monitored.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Rx Only
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Kagocel pills 12mg, 30pcs
Cortexin, 10mg, 5ml, 10pcs
Actovegin pills 200mg, 50pcs
Nootropil pills 800mg, 30pcs
Ingavirin capsules 90mg, 10pcs
Noopept, pills 10mg, 50pcs
No-spa pills 40mg, 64pcs
Belosalic, ointment, 30g
Belosalic, lotion solution for external use spray 100ml
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Phenibut-Vertex pills 250mg, 20pcs
Mildronate capsules 500mg, 90pcs
Fenotropil pills 100mg, 60pcs
Arbidol, capsules 100mg, 40pcs
Daivobet, ointment, 30g
OKI, sachets 80mg 2g, 12pcs
Picamilon pills 50mg, 60pcs 